Vinci Pharmaceuticals Inc. closes over $8 million Series A financing to advance its EPIPLANT™ drug delivery platform.
Amount Raised
$8 Million
Round Type
Series A
Avon By The SeaHealthcareInvestors
Description
Vinci Pharmaceuticals Inc. has successfully closed an $8+ million Series A financing round to further develop its EPIPLANT™ delivery platform. The financing was led by Dynagrow Capital, LLLP, with participation from MintPharma Capital. The funds will support GMP manufacturing and future clinical studies
Who else raised in Healthcare around the same time
Companies in the same sectors as Vinci Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Francis Medical raised an undisclosed amount on November 12, 2026.
- XpertDox LLC raised $20M (Series A) on November 11, 2026.
- Zus Health raised $33M (Series B) on November 10, 2026.
- Silo Pharma raised $815K (Post-IPO Equity) on November 6, 2026.
- Annovis Bio raised $21M (Post-IPO Equity) on November 5, 2026.
- Equinox raised $1B on November 2, 2026.
Who to call at Vinci Pharmaceuticals, Inc., and when
A new round usually means Vinci Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vinci Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vinci Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vinci Pharmaceuticals, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vinci Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansVinci Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.